ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 266 filers reported holding ICU MED INC in Q4 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $42,000 | +13.5% | 224 | -3.4% | 0.00% | – |
Q3 2019 | $37,000 | -15.9% | 232 | +32.6% | 0.00% | – |
Q2 2019 | $44,000 | +12.8% | 175 | +4.2% | 0.00% | – |
Q1 2019 | $39,000 | -40.0% | 168 | -48.5% | 0.00% | -100.0% |
Q4 2018 | $65,000 | -24.4% | 326 | +7.2% | 0.00% | 0.0% |
Q3 2018 | $86,000 | +24.6% | 304 | +10.1% | 0.00% | 0.0% |
Q2 2018 | $69,000 | 0.0% | 276 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $69,000 | +15.0% | 276 | -1.1% | 0.00% | 0.0% |
Q4 2017 | $60,000 | +15.4% | 279 | +0.7% | 0.00% | 0.0% |
Q3 2017 | $52,000 | +13.0% | 277 | +3.4% | 0.00% | 0.0% |
Q2 2017 | $46,000 | +91.7% | 268 | +66.5% | 0.00% | – |
Q1 2017 | $24,000 | -20.0% | 161 | -26.8% | 0.00% | – |
Q4 2016 | $30,000 | -3.2% | 220 | -7.6% | 0.00% | – |
Q3 2016 | $31,000 | +121.4% | 238 | +85.9% | 0.00% | – |
Q2 2016 | $14,000 | +75.0% | 128 | +64.1% | 0.00% | – |
Q1 2016 | $8,000 | -98.1% | 78 | -97.9% | 0.00% | -100.0% |
Q4 2015 | $428,000 | +919.0% | 3,796 | +886.0% | 0.01% | +700.0% |
Q3 2015 | $42,000 | +950.0% | 385 | +795.3% | 0.00% | – |
Q4 2014 | $4,000 | – | 43 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVR Research LP | 22,000 | $4,719,000 | 3.86% |
NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |